[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Charles River Laboratories (CRL)

Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,734,783
  • Shares Outstanding, K 48,168
  • Annual Sales, $ 4,015 M
  • Annual Income, $ -144,340 K
  • EBIT $ 576 M
  • EBITDA $ 1,144 M
  • 60-Month Beta 1.44
  • Price/Sales 1.97
  • Price/Cash Flow 7.49
  • Price/Book 2.69

Options Overview Details

View History
  • Implied Volatility 54.10% (+3.35%)
  • Historical Volatility 59.14%
  • IV Percentile 81%
  • IV Rank 55.68%
  • IV High 71.52% on 02/17/26
  • IV Low 32.21% on 06/18/25
  • Expected Move (DTE 20) 15.90 (8.80%)
  • Put/Call Vol Ratio 1.46
  • Today's Volume 337
  • Volume Avg (30-Day) 269
  • Put/Call OI Ratio 0.29
  • Today's Open Interest 5,953
  • Open Int (30-Day) 4,919
  • Expected Range 164.82 to 196.61

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $2.72
  • Number of Estimates 8
  • High Estimate $3.00
  • Low Estimate $2.47
  • Prior Year $3.12
  • Growth Rate Est. (year over year) -12.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
146.20 +23.61%
on 05/19/26
194.57 -7.12%
on 05/07/26
+16.87 (+10.30%)
since 04/29/26
3-Month
146.20 +23.61%
on 05/19/26
194.57 -7.12%
on 05/07/26
+2.22 (+1.24%)
since 02/27/26
52-Week
132.58 +36.30%
on 06/02/25
228.88 -21.05%
on 01/13/26
+44.46 (+32.63%)
since 05/28/25

Most Recent Stories

More News
Are Wall Street Analysts Bullish on Charles River Laboratories Stock?

Charles River Laboratories has underperformed the S&P 500 over the past 52 weeks, yet Wall Street analysts maintain a highly optimistic outlook about the stock’s prospects.

XLV : 149.47 (-0.93%)
$SPX : 7,580.06 (+0.22%)
CRL : 180.71 (-0.35%)
The 5 Most Interesting Analyst Questions From Charles River Laboratories’s Q1 Earnings Call

The 5 Most Interesting Analyst Questions From Charles River Laboratories’s Q1 Earnings Call

CRL : 180.71 (-0.35%)
NeoGenomics and Charles River Laboratories Shares Plummet, What You Need To Know

NeoGenomics and Charles River Laboratories Shares Plummet, What You Need To Know

NEO : 10.52 (+3.24%)
CRL : 180.71 (-0.35%)
Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions

Partnership showcases a forward- looking collaboration model that highlights advanced testing expertise

CRL : 180.71 (-0.35%)
Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow

Charles River Laboratories International, Inc. (NYSE: CRL) today announced continued momentum in its digital pathology platform, delivering an end-to-end, AI-enabled workflow that significantly accelerates...

CRL : 180.71 (-0.35%)
Charles River Laboratories International Q1 Earnings Call Highlights

Charles River Laboratories International (NYSE:CRL) reported first-quarter 2026 results that management said were in line to slightly ahead of its prior outlook, while reaffirming its full-year organic...

CRL : 180.71 (-0.35%)
CRL Q1 Deep Dive: Portfolio Restructuring and Cost Initiatives Set Stage for Margin Expansion

CRL Q1 Deep Dive: Portfolio Restructuring and Cost Initiatives Set Stage for Margin Expansion

CRL : 180.71 (-0.35%)
Charles River Laboratories (NYSE:CRL) Exceeds Q1 CY2026 Expectations

Charles River Laboratories (NYSE:CRL) Exceeds Q1 CY2026 Expectations

CRL : 180.71 (-0.35%)
Charles River: Q1 Earnings Snapshot

Charles River: Q1 Earnings Snapshot

CRL : 180.71 (-0.35%)
Charles River Laboratories Announces First-Quarter 2026 Results

– Reports First-Quarter Revenue of $995.8 Million, GAAP Loss per Share of $(0.30), and Non-GAAP Earnings per Share of $2.06 – – Reaffirms 2026 Guidance...

CRL : 180.71 (-0.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research...

See More

Key Turning Points

3rd Resistance Point 192.51
2nd Resistance Point 188.67
1st Resistance Point 184.69
Last Price 180.71
1st Support Level 176.87
2nd Support Level 173.03
3rd Support Level 169.05

See More

52-Week High 228.88
Fibonacci 61.8% 192.09
Fibonacci 50% 180.73
Last Price 180.71
Fibonacci 38.2% 169.37
52-Week Low 132.58

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.